GlobeNewswire 10/3/2025 Luke Bryan and Bayer discuss the Take Care, Now campaign With YourUpdateTV
GlobeNewswire 10/2/2025 AskBio Announces 6 Presentations at the European Society of Gene and Cell Therapy 32nd Annual Meetin...
GlobeNewswire 9/30/2025 Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Ganesh Kama...
GlobeNewswire 9/26/2025 Evkeeza® (evinacumab-dgnb) ANGPTL3 Antibody Approved in the U.S. for Children as Young as 1 Year Old...
GlobeNewswire 9/25/2025 BotCity Secures $12 Million Series A Funding to Address Growing Risks in “Shadow Automation”
GlobeNewswire 9/24/2025 Daré Bioscience to Receive up to $499,000 to Support Preeclampsia Research
GlobeNewswire 9/24/2025 BIO-Europe® 2025: Vienna Prepares to Welcome Global Biopharma Leaders
GlobeNewswire 9/22/2025 First European Participants Randomized in AskBio Phase 2 Gene Therapy Trial of AB-1005 for Parkinson...
GlobeNewswire 9/22/2025 First Parkinson’s disease patient treated in BlueRock’s pivotal Phase III trial of investigational c...
GlobeNewswire 9/22/2025 Press Release: Sanofi and Regeneron’s Dupixent to treat chronic spontaneous urticaria advances in EU...
GlobeNewswire 9/22/2025 Dupixent® (dupilumab) to Treat Chronic Spontaneous Urticaria (CSU) Advances in EU with Positive CHMP...
GlobeNewswire 9/19/2025 Alvotech Announces Marketing Approval in Japan of Three New Biosimilars
GlobeNewswire 9/19/2025 Regeneron Donates Ebola Treatment for Use in Countries Most at Risk of Outbreaks
GlobeNewswire 9/17/2025 Results from Phase 2 COURAGE Trial Demonstrating Potential to Improve Quality of GLP-1 receptor agon...
GlobeNewswire 9/17/2025 AskBio Announces Completion of Enrollment in Phase 1 Clinical Trial of AB-1005 Gene Therapy for Mult...
GlobeNewswire 9/17/2025 Regeneron Announces Positive Phase 3 Trial in Adults with Ultra-Rare Genetic Disorder Fibrodysplasia...
GlobeNewswire 9/16/2025 Expert with Bayer Discusses the U.S. Launch of Aspirina Families with YourUpdateTV
GlobeNewswire 9/16/2025 Parexel Announces Appointment of Rob Goodwin as Chief Operating Officer
GlobeNewswire 9/16/2025 Indicium Receives Investment from Databricks Ventures
TeleTrader 9/11/2025 Europe closes higher after ECB decision
GlobeNewswire 9/10/2025 Dewpoint Therapeutics Closes Series D Financing to Advance First-in-Class Condensate Modulator (c-mo...
GlobeNewswire 9/9/2025 Libtayo® (cemiplimab) Plus Chemotherapy Results at Five Years Reinforce Significant and Durable Impr...
GlobeNewswire 9/8/2025 DIH Appoints Barrett Mooney, Ph.D to DIH Holding US, Inc. Board of Directors 
GlobeNewswire 9/8/2025 Regeneron Advances Allergy Pipeline with Two Positive Phase 3 Trials Evaluating First-in-Class Antib...
GlobeNewswire 9/8/2025 CHARM Therapeutics Appoints Dr Erkut Bahceci as Chief Medical Officer